Aaron Chen

This publication record spans several distinct clinical topics rather than a single focused research program, including clinical trials of the cancer drug olomorasib (a KRAS G12C inhibitor) for lung, colorectal, and other solid tumors, retrospective studies on dermatology and metabolic drugs (GLP-1 receptor agonists, psoriasis), and emergency medicine practice studies. Given the topic breadth and mix of author roles implied by large multi-site trials, this may represent contributions from a clinician involved in multiple collaborative research efforts rather than a single specialized lab. Prospective students should note the work centers on clinical and translational studies (clinical trials, retrospective cohort analyses) rather than basic laboratory science.

Publication output fluctuated over the past decade with a dip around 2019-2023, followed by a marked increase in 2024-2025, suggesting growing recent activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026